Lawsuits filed against Pfizer, the manufacturer of Depo-Provera, allege that the pharmaceutical giant knew or should have known about the potential risk associated with the long-term use of Depo-Provera but failed to warn healthcare providers and patients
Nature 454(7204):656660 Strasser GA, Kaminker JS, Tessier-Lavigne M (2010) Microarray analysis of retinal endothelial tip cells identifies CXCR11 as a mediator of tip cell morphology and branching
Well delve into this topic by examining a case study in the medical literature through the DrugCard platform
In dendritic cells, butyrate and propionate can impede their normal differentiation and induce an immune tolerant phenotype
If you are receiving treatment, talk to your doctor before using the supplement
Viehbacher, President and CEO